Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
186.93
-3.37 (-1.77%)
At close: Oct 28, 2025, 4:00 PM EDT
186.75
-0.18 (-0.10%)
After-hours: Oct 28, 2025, 7:12 PM EDT

Johnson & Johnson Revenue

Johnson & Johnson had revenue of $23.99B in the quarter ending September 28, 2025, with 6.77% growth. This brings the company's revenue in the last twelve months to $92.15B, up 5.08% year-over-year. In the year 2024, Johnson & Johnson had annual revenue of $88.82B with 4.30% growth.

Revenue (ttm)
$92.15B
Revenue Growth
+5.08%
P/S Ratio
4.97
Revenue / Employee
$667,263
Employees
138,100
Market Cap
449.42B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 29, 202488.82B3.66B4.30%
Dec 31, 202385.16B5.17B6.46%
Jan 1, 202379.99B1.25B1.59%
Jan 2, 202278.74B-3.84B-4.65%
Jan 3, 202182.58B525.00M0.64%
Dec 29, 2019 Pro Pro Pro
Dec 30, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Jan 1, 2017 Pro Pro Pro
Jan 3, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Abbott Laboratories43.84B
Revenue Rankings